Clinical Trial Update: A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intravenous iron isomaltoside 1000 (Monofer) as monotherapy to oral iron sulfate for chemotherapy-induced anemia in patients with non-my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Anemia
• Non-myeloid Malignancies

Drugs mentioned

• Ferrous sulfate (ferrous sulfate)
• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Non-myeloid Malignancies, Chemotherapy Induced Anaemia | Phase 3 | Status: COMPLETED | Results posted: 2015-12-03